Jagsonpal Pharmaceuticals Ltd. NSE: JAGSNPHARM | BSE: 507789

Mid-range Performer

Download real time

248.02 -2.08 (-0.83%)

62.00% Gain from 52W Low

40,054

NSE+BSE Volume

NSE 16 Sep, 2025 11:08 AM (IST)

Jagsonpal Pharmaceuticals Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Jagsonpal Pharmaceuticals Ltd. on BSE

Load latest

Jagsonpal Pharmaceuticals Ltd.

26 Jul 2025

248.02

-0.83%

Board Meeting

Jagsonpal Pharmaceuticals Ltd - 507789 - Board Meeting Outcome for Outcome Of Board Meeting Along With …

BSE India

Outcome of Board Meeting Held on July 26, 2025 along with the Unaudited Financial Results for the quarter ended June 30, 2025.

Jagsonpal Pharmaceuticals Ltd.

24 Jul 2025

248.02

-0.83%

Company Update

Jagsonpal Pharmaceuticals Ltd - 507789 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

BSE India

Allotment of Equity Shares under the Jagsonpal Pharmaceuticals Limited Employee Stock Option Plan, 2022

Jagsonpal Pharmaceuticals Ltd.

24 Jul 2025

248.02

-0.83%

Company Update

Jagsonpal Pharmaceuticals Ltd - 507789 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

BSE India

Intimation for Grant of Employees Stock Options

Jagsonpal Pharmaceuticals Ltd.

23 Jul 2025

248.02

-0.83%

Company Update

Jagsonpal Pharmaceuticals Ltd - 507789 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Company, as a part of its investors engagement activities, has scheduled a conference call with the Analysts / Investors on Monday, July 28, 2025, to discuss its Q1 FY26 financial results. The Conference call details is attached as Annexure. We request you to take the above on record.

Jagsonpal Pharmaceuticals Ltd.

23 Jul 2025

248.02

-0.83%

Board Meeting

Jagsonpal Pharmaceuticals Ltd - 507789 - Board Meeting Intimation for Consideration And Approval Of Un- Audited …

BSE India

Jagsonpal Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/07/2025 ,inter alia, to consider and approve Un- Audited Financial Results for the quarter ended June 30, 2025

Jagsonpal Pharmaceuticals Ltd.

08 Jul 2025

248.02

-0.83%

Company Update

Jagsonpal Pharmaceuticals Ltd - 507789 - Announcement under Regulation 30 (LODR)-Cessation

BSE India

Cessation of Employment of Mr. Sachin Jain, Chief Financial Officer of the Company

Jagsonpal Pharmaceuticals Ltd.

07 Jul 2025

248.02

-0.83%

Company Update

Jagsonpal Pharmaceuticals Ltd - 507789 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Compliance Certificate under Reg 74(5) of SEBI (D&P) Reg, 2018 for the quarter ended on 30 June, 2025

Jagsonpal Pharmaceuticals Ltd.

26 Jun 2025

248.02

-0.83%

SAST

Jagsonpal Pharmaceuticals Ltd - 507789 - Closure of Trading Window

BSE India

Intimation for Closure of Trading Window

Jagsonpal Pharmaceuticals Ltd.

16 Jun 2025

248.02

-0.83%

Company Update

Jagsonpal Pharmaceuticals Ltd - 507789 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

We wish to inform you that the Company will participate in Group Conference (In-Person) on 26 June, 2025

Jagsonpal Pharmaceuticals Ltd.

11 Jun 2025

248.02

-0.83%

Company Update

Jagsonpal Pharmaceuticals Ltd - 507789 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

BSE India

Allotment of Equity Shares under the Jagsonpal Pharmaceuticals Limited Employees Stock Options Plan, 2022

Is Jagsonpal Pharmaceuticals Ltd. worth buying?

78 Votes:

Buy 78.21%

Sell 11.54%

Hold 10.26%